RSA 415:18-l Coverage Required for Qualified Clinical Trials.

I. In this section:
(a) "Clinical trials of emerging technologies" mean Phase I and Phase II clinical trials.
(b) "Clinical trials of leading therapeutic or diagnostic alternatives" mean Phase III and Phase IV clinical trials.
(c) "Cooperative group" means a formal network of facilities that collaborate on research projects and have an established National Institute of Health (NIH) approved peer review program operating within the group.
(d) "FDA" means the federal Food and Drug Administration.
(e) "Member" means the policyholder, subscriber, insured, or certificate holder, or a covered dependent of a policyholder, subscriber, insured, or certificate holder.
(f) "Multiple project assurance contract" means a contract between an institution and the